| | | |
Outcomes (% Cases)
|
---|
| | | |
Concordant treatment
|
Discordant treatment
|
---|
Sample age groups
|
Antibiotic
|
% cases receiving antibiotic
|
% cases treated discordantly
|
% simple cure
|
% delayed cure
|
% delayed cure and hospitalized
|
% simple cure
|
% delayed cure
|
% delayed cure and hospitalized
|
---|
Pediatric (0- < 5 yrs)
|
Amoxicillin (High dose)
|
9%
|
37%
|
71%
|
24%
|
5%
|
69%
|
23%
|
8%
|
Amoxicillin (Low dose)
|
7%
|
37%
|
71%
|
24%
|
5%
|
68%
|
23%
|
9%
|
Augmentin
|
11%
|
37%
|
71%
|
24%
|
5%
|
69%
|
23%
|
8%
|
Azithromycin
|
28%
|
32%
|
71%
|
24%
|
5%
|
45%
|
15%
|
40%
|
Oral Cephalosporin (2nd generation)
|
7%
|
8%
|
71%
|
24%
|
5%
|
68%
|
22%
|
10%
|
Oral Cephalosporin (3rd generation)
|
24%
|
8%
|
71%
|
24%
|
5%
|
68%
|
22%
|
10%
|
IM Ceftriaxone
|
14%
|
8%
|
71%
|
24%
|
5%
|
68%
|
23%
|
10%
|
Adult (50- < 65 yrs)
|
Amoxicillin
|
2%
|
37%
|
81%
|
14%
|
5%
|
77%
|
14%
|
9%
|
Augmentin
|
19%
|
37%
|
81%
|
14%
|
5%
|
77%
|
14%
|
9%
|
Azithromycin
|
15%
|
29%
|
81%
|
14%
|
5%
|
51%
|
9%
|
40%
|
Oral Cephalosporin (3rd generation)
|
9%
|
6%
|
81%
|
14%
|
5%
|
77%
|
14%
|
10%
|
IM Ceftriaxone
|
5%
|
6%
|
81%
|
14%
|
5%
|
77%
|
14%
|
10%
|
Fluoroquinolones
|
56%
|
1%
|
81%
|
14%
|
5%
|
51%
|
9%
|
40%
|
- *Derived from reference 11. Two age groups are shown as examples of model assumptions and inputs.